FDA
Pharma

New FDA oncology chief sets priorities in first interview

Hiring more staff and deploying AI are among the OCE’s priorities, Angelo de Claro told Fierce in his first interview as FDA’s oncology chief.
Angus Liu Sep 11, 2026 4:00am
GSK

GSK prepares frontline FDA bid for lung cancer drug Jideytro

Sep 13, 2026 7:00pm
Enhertu

Increased deaths shadow Enhertu’s first-line lung cancer data

Sep 13, 2026 7:00pm
fight

Ivonescimab tops Keytruda with strong OS in PD-L1-high NSCLC

Sep 13, 2026 8:00am
dart board miss failure

Failed Trodelvy first-line NSCLC trial shows better China data

Sep 12, 2026 9:45pm
AZ

AstraZeneca’s Etcamah flunks first-line breast cancer trial

Sep 12, 2026 12:43pm
More News

Handa's Cabometyx formulation no threat to Exelixis: analysts

Sep 11, 2026 2:06pm

The Oral GLP-1 Tracker: Novo, Lilly obesity pills grow scripts

Sep 11, 2026 10:15am

Takeda, Daiichi, Samsung Bio and more—Fierce Pharma Asia

Sep 11, 2026 9:15am

Lonza invests in US plant; CordenPharma scales injectables

Sep 10, 2026 3:50pm